Compounded semaglutide
Compounded semaglutide is semaglutide prepared by a compounding pharmacy rather than manufactured and packaged by Novo Nordisk (the maker of Ozempic and Wegovy). It surged in popularity during the brand-name shortages because it’s typically far cheaper and was easier to obtain. It also comes with genuine caveats that are worth understanding plainly, not glossed over.
Why it exists
US law allows compounding pharmacies to make versions of a drug under specific conditions — notably when the FDA lists the brand drug as being in shortage. That’s the legal door most compounded GLP-1s came through. As shortages officially resolve, that door narrows, and the regulatory picture around compounded semaglutide has been actively shifting — a reason to check current status rather than rely on an old forum post.
The honest safety picture
This is not the FDA-approved product. Key points patients deserve to know:
- Not FDA-reviewed: compounded versions haven’t been through the FDA’s approval process for safety, effectiveness, or manufacturing quality.
- Salt forms: the FDA has specifically warned about compounded products using semaglutide salts (semaglutide sodium/acetate), which differ from the approved active ingredient.
- Dosing errors: several reports of overdoses have involved patients self-measuring from multi-dose vials rather than pre-set pens — a math step the brand pens remove.
- Source quality varies enormously between a licensed pharmacy and an unregulated online seller.
The takeaway
Plenty of people have used compounded semaglutide, and cost is a real barrier the brand products create. But “same drug, cheaper” understates the differences. If you’re considering or using it, do it through a licensed pharmacy with a real prescriber relationship, be precise about dosing, and keep a careful dose log — self-measured dosing is exactly where errors happen.
This is educational information, not a recommendation for or against. Discuss it with a qualified prescriber.